| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.09e-06 | 46 | 14 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.64e-05 | 9 | 14 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.64e-05 | 9 | 14 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | phosphatase binding | 2.69e-05 | 264 | 14 | 4 | GO:0019902 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.13e-05 | 14 | 14 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | calcium channel activity | 9.10e-05 | 129 | 14 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.45e-04 | 151 | 14 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.48e-04 | 152 | 14 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.52e-04 | 182 | 14 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.60e-04 | 184 | 14 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 3.83e-04 | 210 | 14 | 3 | GO:0019903 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.47e-03 | 334 | 14 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.59e-03 | 343 | 14 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 1.99e-03 | 815 | 14 | 4 | GO:0042803 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.26e-03 | 102 | 14 | 2 | GO:0001540 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.64e-03 | 459 | 14 | 3 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.77e-03 | 465 | 14 | 3 | GO:0046873 | |
| GeneOntologyMolecularFunction | channel activity | 5.30e-03 | 525 | 14 | 3 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.33e-03 | 526 | 14 | 3 | GO:0022803 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 6.27e-03 | 172 | 14 | 2 | GO:0044325 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 8.11e-03 | 1205 | 14 | 4 | GO:0046983 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 8.66e-03 | 627 | 14 | 3 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.01e-02 | 664 | 14 | 3 | GO:0008324 | |
| GeneOntologyMolecularFunction | calcium ion binding | 1.40e-02 | 749 | 14 | 3 | GO:0005509 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 1.45e-02 | 758 | 14 | 3 | GO:0015318 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.55e-02 | 276 | 14 | 2 | GO:0003730 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.64e-02 | 793 | 14 | 3 | GO:0015075 | |
| GeneOntologyMolecularFunction | amide binding | 1.81e-02 | 299 | 14 | 2 | GO:0033218 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.91e-02 | 308 | 14 | 2 | GO:0008017 | |
| GeneOntologyMolecularFunction | peptide binding | 2.03e-02 | 318 | 14 | 2 | GO:0042277 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse, modulating synaptic transmission | 1.28e-06 | 3 | 14 | 2 | GO:0099577 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse | 1.28e-06 | 3 | 14 | 2 | GO:0140244 | |
| GeneOntologyBiologicalProcess | regulation of translation at synapse, modulating synaptic transmission | 1.54e-05 | 9 | 14 | 2 | GO:0099547 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term neuronal synaptic plasticity | 2.34e-05 | 11 | 14 | 2 | GO:0048170 | |
| GeneOntologyBiologicalProcess | regulation of translation at synapse | 3.32e-05 | 13 | 14 | 2 | GO:0140243 | |
| GeneOntologyBiologicalProcess | calcium ion import | 3.64e-05 | 98 | 14 | 3 | GO:0070509 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 6.35e-05 | 118 | 14 | 3 | GO:0046928 | |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 7.53e-05 | 125 | 14 | 3 | GO:0016079 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter transport | 1.08e-04 | 141 | 14 | 3 | GO:0051588 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.11e-04 | 392 | 14 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 2.18e-04 | 179 | 14 | 3 | GO:0031023 | |
| GeneOntologyBiologicalProcess | signal release from synapse | 2.80e-04 | 195 | 14 | 3 | GO:0099643 | |
| GeneOntologyBiologicalProcess | neurotransmitter secretion | 2.80e-04 | 195 | 14 | 3 | GO:0007269 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 3.01e-04 | 509 | 14 | 4 | GO:0006816 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 3.29e-04 | 40 | 14 | 2 | GO:0048169 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 3.46e-04 | 41 | 14 | 2 | GO:1901020 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 3.84e-04 | 217 | 14 | 3 | GO:0097553 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 4.74e-04 | 48 | 14 | 2 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 4.74e-04 | 48 | 14 | 2 | GO:1902656 | |
| GeneOntologyBiologicalProcess | response to pain | 5.35e-04 | 51 | 14 | 2 | GO:0048265 | |
| GeneOntologyBiologicalProcess | centriole assembly | 5.78e-04 | 53 | 14 | 2 | GO:0098534 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 6.43e-04 | 259 | 14 | 3 | GO:0006836 | |
| GeneOntologyBiologicalProcess | negative regulation of cation channel activity | 6.45e-04 | 56 | 14 | 2 | GO:2001258 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 6.80e-04 | 264 | 14 | 3 | GO:0099504 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 7.65e-04 | 61 | 14 | 2 | GO:1904645 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 8.19e-04 | 663 | 14 | 4 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 8.23e-04 | 664 | 14 | 4 | GO:0099177 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 9.02e-04 | 291 | 14 | 3 | GO:0045055 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 9.22e-04 | 67 | 14 | 2 | GO:0099171 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 9.78e-04 | 69 | 14 | 2 | GO:1903170 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 1.20e-03 | 321 | 14 | 3 | GO:0099003 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 1.22e-03 | 323 | 14 | 3 | GO:0051924 | |
| GeneOntologyBiologicalProcess | centrosome duplication | 1.34e-03 | 81 | 14 | 2 | GO:0051298 | |
| GeneOntologyBiologicalProcess | regulation of neuronal synaptic plasticity | 1.41e-03 | 83 | 14 | 2 | GO:0048168 | |
| GeneOntologyBiologicalProcess | negative regulation of ion transmembrane transporter activity | 1.55e-03 | 87 | 14 | 2 | GO:0032413 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 1.73e-03 | 92 | 14 | 2 | GO:1901019 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transport | 1.73e-03 | 92 | 14 | 2 | GO:0051926 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 1.97e-03 | 1446 | 14 | 5 | GO:0010628 | |
| GeneOntologyBiologicalProcess | negative regulation of transporter activity | 2.46e-03 | 110 | 14 | 2 | GO:0032410 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.55e-03 | 112 | 14 | 2 | GO:0019226 | |
| GeneOntologyBiologicalProcess | negative regulation of cation transmembrane transport | 2.73e-03 | 116 | 14 | 2 | GO:1904063 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 2.77e-03 | 922 | 14 | 4 | GO:0098662 | |
| GeneOntologyBiologicalProcess | exocytosis | 2.83e-03 | 434 | 14 | 3 | GO:0006887 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 2.87e-03 | 931 | 14 | 4 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 2.87e-03 | 931 | 14 | 4 | GO:0007268 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 2.96e-03 | 939 | 14 | 4 | GO:0099537 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 3.00e-03 | 942 | 14 | 4 | GO:0098655 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 3.06e-03 | 123 | 14 | 2 | GO:0120034 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transmembrane transport | 3.11e-03 | 124 | 14 | 2 | GO:0034766 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 3.21e-03 | 126 | 14 | 2 | GO:0033555 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 3.41e-03 | 976 | 14 | 4 | GO:0099536 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 3.66e-03 | 475 | 14 | 3 | GO:0140694 | |
| GeneOntologyBiologicalProcess | metal ion transport | 3.72e-03 | 1000 | 14 | 4 | GO:0030001 | |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 3.84e-03 | 138 | 14 | 2 | GO:2001257 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 3.95e-03 | 1017 | 14 | 4 | GO:0098660 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 4.06e-03 | 142 | 14 | 2 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 4.06e-03 | 142 | 14 | 2 | GO:0098659 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 4.06e-03 | 493 | 14 | 3 | GO:0010959 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.23e-03 | 145 | 14 | 2 | GO:0051028 | |
| GeneOntologyBiologicalProcess | microtubule-based process | 4.56e-03 | 1058 | 14 | 4 | GO:0007017 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 4.57e-03 | 151 | 14 | 2 | GO:0045727 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 5.37e-03 | 164 | 14 | 2 | GO:0007098 | |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 5.43e-03 | 165 | 14 | 2 | GO:1903305 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 5.50e-03 | 1115 | 14 | 4 | GO:0034220 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transport | 5.82e-03 | 171 | 14 | 2 | GO:0043271 | |
| GeneOntologyBiologicalProcess | RNA transport | 6.09e-03 | 175 | 14 | 2 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 6.09e-03 | 175 | 14 | 2 | GO:0050657 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane transport | 6.09e-03 | 175 | 14 | 2 | GO:0034763 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.24e-04 | 46 | 14 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | cation channel complex | 4.66e-04 | 235 | 14 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.07e-03 | 73 | 14 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 1.69e-03 | 817 | 14 | 4 | GO:0098978 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 1.83e-03 | 96 | 14 | 2 | GO:0010494 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.84e-03 | 378 | 14 | 3 | GO:0034702 | |
| GeneOntologyCellularComponent | dendrite | 2.03e-03 | 858 | 14 | 4 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 2.05e-03 | 860 | 14 | 4 | GO:0097447 | |
| GeneOntologyCellularComponent | presynapse | 2.28e-03 | 886 | 14 | 4 | GO:0098793 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.90e-03 | 141 | 14 | 2 | GO:0048786 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.61e-03 | 523 | 14 | 3 | GO:1902495 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 4.69e-03 | 155 | 14 | 2 | GO:0098685 | |
| GeneOntologyCellularComponent | transporter complex | 5.31e-03 | 550 | 14 | 3 | GO:1990351 | |
| GeneOntologyCellularComponent | ciliary basal body | 7.32e-03 | 195 | 14 | 2 | GO:0036064 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 7.38e-03 | 1228 | 14 | 4 | GO:0036477 | |
| GeneOntologyCellularComponent | axon terminus | 8.44e-03 | 210 | 14 | 2 | GO:0043679 | |
| GeneOntologyCellularComponent | perikaryon | 9.47e-03 | 223 | 14 | 2 | GO:0043204 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 1.01e-02 | 230 | 14 | 2 | GO:0098562 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.03e-02 | 233 | 14 | 2 | GO:0044306 | |
| GeneOntologyCellularComponent | ribosome | 1.34e-02 | 267 | 14 | 2 | GO:0005840 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 269 | 14 | 2 | GO:0036464 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.43e-02 | 277 | 14 | 2 | GO:0042734 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.53e-02 | 287 | 14 | 2 | GO:0035770 | |
| MousePheno | abnormal thermal nociception | 4.00e-06 | 168 | 10 | 4 | MP:0002733 | |
| MousePheno | hypoalgesia | 4.19e-06 | 170 | 10 | 4 | MP:0003043 | |
| MousePheno | abnormal pain threshold | 2.50e-05 | 267 | 10 | 4 | MP:0001970 | |
| MousePheno | increased thermal nociceptive threshold | 5.17e-05 | 108 | 10 | 3 | MP:0001973 | |
| MousePheno | abnormal nerve fiber response | 5.50e-05 | 16 | 10 | 2 | MP:0003477 | |
| MousePheno | abnormal miniature excitatory postsynaptic currents | 6.40e-05 | 116 | 10 | 3 | MP:0004753 | |
| MousePheno | abnormal touch/ nociception | 9.51e-05 | 376 | 10 | 4 | MP:0001968 | |
| MousePheno | impaired conditioned place preference behavior | 1.48e-04 | 26 | 10 | 2 | MP:0009712 | |
| MousePheno | abnormal channel response | 2.40e-04 | 33 | 10 | 2 | MP:0003484 | |
| MousePheno | abnormal conditioned place preference behavior | 2.71e-04 | 35 | 10 | 2 | MP:0009711 | |
| MousePheno | increased aggression towards mice | 3.72e-04 | 41 | 10 | 2 | MP:0001353 | |
| MousePheno | hyporesponsive to tactile stimuli | 4.49e-04 | 45 | 10 | 2 | MP:0005498 | |
| MousePheno | abnormal pericardium morphology | 4.54e-04 | 225 | 10 | 3 | MP:0000288 | |
| MousePheno | decreased fear-related response | 4.89e-04 | 47 | 10 | 2 | MP:0003460 | |
| MousePheno | hydrops fetalis | 6.22e-04 | 53 | 10 | 2 | MP:0002192 | |
| MousePheno | abnormal spatial learning | 8.24e-04 | 276 | 10 | 3 | MP:0001463 | |
| MousePheno | enhanced behavioral response to xenobiotic | 1.05e-03 | 69 | 10 | 2 | MP:0009746 | |
| MousePheno | abnormal inhibitory postsynaptic currents | 1.08e-03 | 70 | 10 | 2 | MP:0002945 | |
| MousePheno | abnormal nonmotile primary cilium morphology | 1.08e-03 | 70 | 10 | 2 | MP:0013205 | |
| MousePheno | abnormal aggression towards conspecific | 1.18e-03 | 73 | 10 | 2 | MP:0021115 | |
| MousePheno | abnormal fear-related response | 1.21e-03 | 74 | 10 | 2 | MP:0003106 | |
| MousePheno | increased aggression | 1.31e-03 | 77 | 10 | 2 | MP:0005655 | |
| MousePheno | abnormal nervous system electrophysiology | 1.37e-03 | 329 | 10 | 3 | MP:0002272 | |
| MousePheno | abnormal avoidance learning behavior | 1.94e-03 | 94 | 10 | 2 | MP:0001462 | |
| MousePheno | abnormal excitatory postsynaptic potential | 2.28e-03 | 102 | 10 | 2 | MP:0002912 | |
| MousePheno | pericardial effusion | 2.70e-03 | 111 | 10 | 2 | MP:0005312 | |
| MousePheno | abnormal social/conspecific interaction behavior | 2.78e-03 | 421 | 10 | 3 | MP:0002557 | |
| MousePheno | abnormal fear/anxiety-related behavior | 2.83e-03 | 919 | 10 | 4 | MP:0002065 | |
| MousePheno | abnormal primary cilium morphology | 2.84e-03 | 114 | 10 | 2 | MP:0013203 | |
| MousePheno | abnormal primitive node morphology | 2.99e-03 | 117 | 10 | 2 | MP:0004066 | |
| MousePheno | abnormal aggression-related behavior | 3.51e-03 | 127 | 10 | 2 | MP:0002061 | |
| MousePheno | abnormal CNS synaptic transmission | 3.65e-03 | 985 | 10 | 4 | MP:0002206 | |
| MousePheno | impaired coordination | 3.98e-03 | 478 | 10 | 3 | MP:0001405 | |
| MousePheno | reduced long-term potentiation | 4.31e-03 | 141 | 10 | 2 | MP:0001473 | |
| MousePheno | impaired learning | 4.61e-03 | 146 | 10 | 2 | MP:0012315 | |
| MousePheno | abnormal spinal reflex | 4.74e-03 | 148 | 10 | 2 | MP:0012079 | |
| MousePheno | abnormal response to tactile stimuli | 4.74e-03 | 148 | 10 | 2 | MP:0005316 | |
| MousePheno | increased exploration in new environment | 4.86e-03 | 150 | 10 | 2 | MP:0001415 | |
| MousePheno | abnormal synaptic transmission | 4.93e-03 | 1070 | 10 | 4 | MP:0003635 | |
| MousePheno | effusion | 4.99e-03 | 152 | 10 | 2 | MP:0021205 | |
| MousePheno | abnormal synaptic physiology | 5.03e-03 | 1076 | 10 | 4 | MP:0021009 | |
| MousePheno | convulsive seizures | 5.06e-03 | 153 | 10 | 2 | MP:0000947 | |
| MousePheno | postnatal lethality | 5.17e-03 | 1084 | 10 | 4 | MP:0002082 | |
| Domain | FXMRP1_C_core | 1.34e-06 | 3 | 13 | 2 | IPR022034 | |
| Domain | Agenet | 1.34e-06 | 3 | 13 | 2 | PF05641 | |
| Domain | AGENET_LIKE | 1.34e-06 | 3 | 13 | 2 | PS51641 | |
| Domain | FXMRP1_C_core | 1.34e-06 | 3 | 13 | 2 | PF12235 | |
| Domain | Agenet-like_dom | 1.34e-06 | 3 | 13 | 2 | IPR008395 | |
| Domain | Channel_four-helix_dom | 7.54e-06 | 57 | 13 | 3 | IPR027359 | |
| Domain | - | 7.54e-06 | 57 | 13 | 3 | 1.20.120.350 | |
| Domain | Ca_chan_IQ | 9.37e-06 | 7 | 13 | 2 | PF08763 | |
| Domain | GPHH | 9.37e-06 | 7 | 13 | 2 | PF16905 | |
| Domain | GPHH_dom | 9.37e-06 | 7 | 13 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 9.37e-06 | 7 | 13 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 9.37e-06 | 7 | 13 | 2 | SM01062 | |
| Domain | VDCCAlpha1 | 2.01e-05 | 10 | 13 | 2 | IPR002077 | |
| Domain | KH_1 | 3.10e-04 | 38 | 13 | 2 | PF00013 | |
| Domain | - | 3.27e-04 | 39 | 13 | 2 | 3.30.1370.10 | |
| Domain | KH | 3.44e-04 | 40 | 13 | 2 | SM00322 | |
| Domain | KH_dom | 3.44e-04 | 40 | 13 | 2 | IPR004087 | |
| Domain | KH_TYPE_1 | 3.79e-04 | 42 | 13 | 2 | PS50084 | |
| Domain | KH_dom_type_1 | 4.16e-04 | 44 | 13 | 2 | IPR004088 | |
| Domain | EF_HAND_2 | 4.87e-04 | 231 | 13 | 3 | PS50222 | |
| Domain | EF_hand_dom | 4.94e-04 | 232 | 13 | 3 | IPR002048 | |
| Domain | Ion_trans_dom | 2.76e-03 | 114 | 13 | 2 | IPR005821 | |
| Domain | Ion_trans | 2.76e-03 | 114 | 13 | 2 | PF00520 | |
| Domain | EF-hand-dom_pair | 1.64e-02 | 287 | 13 | 2 | IPR011992 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.48e-05 | 11 | 10 | 2 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 2.48e-05 | 11 | 10 | 2 | M47958 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 2.48e-05 | 11 | 10 | 2 | MM14498 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.14e-04 | 23 | 10 | 2 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.35e-04 | 25 | 10 | 2 | M47948 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 4.81e-04 | 47 | 10 | 2 | M19708 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 5.67e-04 | 51 | 10 | 2 | M39457 | |
| Pathway | WP_MAPK_SIGNALING | 5.75e-04 | 246 | 10 | 3 | M39597 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 5.89e-04 | 52 | 10 | 2 | M5785 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 7.31e-04 | 267 | 10 | 3 | M10792 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 1.16e-03 | 73 | 10 | 2 | MM16641 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.60e-03 | 147 | 10 | 2 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 4.85e-03 | 151 | 10 | 2 | M39329 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.67e-03 | 178 | 10 | 2 | M2890 | |
| Pathway | WP_RAS_SIGNALING | 7.12e-03 | 184 | 10 | 2 | M39764 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 9.27e-03 | 211 | 10 | 2 | MM14502 | |
| Pubmed | On the aggregation properties of FMRP--a link with the FXTAS syndrome? | 1.50e-07 | 2 | 14 | 2 | 21446998 | |
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.50e-07 | 2 | 14 | 2 | 23426690 | |
| Pubmed | Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models. | 1.50e-07 | 2 | 14 | 2 | 19244359 | |
| Pubmed | The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits. | 1.50e-07 | 2 | 14 | 2 | 19193898 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 38155373 | ||
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 28919851 | ||
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 15050706 | ||
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 16675531 | ||
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 23376566 | ||
| Pubmed | The Fragile X proteins Fmrp and Fxr2p cooperate to regulate glucose metabolism in mice. | 1.50e-07 | 2 | 14 | 2 | 25552647 | |
| Pubmed | LLPS of FXR proteins drives replication organelle clustering for β-coronaviral proliferation. | 4.51e-07 | 3 | 14 | 2 | 38587486 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 10888599 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 38996073 | ||
| Pubmed | Fragile X-related proteins regulate mammalian circadian behavioral rhythms. | 4.51e-07 | 3 | 14 | 2 | 18589395 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 29466725 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 26051932 | ||
| Pubmed | Spatial control of nucleoporin condensation by fragile X-related proteins. | 4.51e-07 | 3 | 14 | 2 | 32706158 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 12417522 | ||
| Pubmed | The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. | 4.51e-07 | 3 | 14 | 2 | 7489725 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 8668200 | ||
| Pubmed | Evidence that fragile X mental retardation protein is a negative regulator of translation. | 4.51e-07 | 3 | 14 | 2 | 11157796 | |
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 4.51e-07 | 3 | 14 | 2 | 24523520 | |
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 4.51e-07 | 3 | 14 | 2 | 24394417 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 27770568 | ||
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 4.51e-07 | 3 | 14 | 2 | 29208674 | |
| Pubmed | Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer. | 4.51e-07 | 3 | 14 | 2 | 32878499 | |
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 4.51e-07 | 3 | 14 | 2 | 26507659 | |
| Pubmed | Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes. | 4.51e-07 | 3 | 14 | 2 | 26612855 | |
| Pubmed | Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. | 4.51e-07 | 3 | 14 | 2 | 9259278 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 19487368 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 26109663 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 20442204 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 9.02e-07 | 4 | 14 | 2 | 32616470 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 26283199 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 9.02e-07 | 4 | 14 | 2 | 37141091 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 31253182 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 10567518 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 15728831 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 16571602 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 9.02e-07 | 4 | 14 | 2 | 15953418 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 18664458 | ||
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 9.02e-07 | 4 | 14 | 2 | 25483588 | |
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 10556305 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 8825650 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 11296258 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 16787652 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 15451373 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 2.25e-06 | 6 | 14 | 2 | 35324301 | |
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 9238069 | ||
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 11438699 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 2.25e-06 | 6 | 14 | 2 | 12827191 | |
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 10328888 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 3.16e-06 | 7 | 14 | 2 | 35176221 | |
| Pubmed | 5.41e-06 | 9 | 14 | 2 | 16382099 | ||
| Pubmed | Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. | 6.76e-06 | 10 | 14 | 2 | 19235102 | |
| Pubmed | 8.26e-06 | 11 | 14 | 2 | 29142209 | ||
| Pubmed | 8.26e-06 | 11 | 14 | 2 | 22022532 | ||
| Pubmed | FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124. | 8.26e-06 | 11 | 14 | 2 | 21957233 | |
| Pubmed | 1.37e-05 | 14 | 14 | 2 | 21228161 | ||
| Pubmed | 1.58e-05 | 15 | 14 | 2 | 20188150 | ||
| Pubmed | 1.58e-05 | 15 | 14 | 2 | 24453333 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 2.77e-05 | 462 | 14 | 4 | 31138677 | |
| Pubmed | 3.15e-05 | 21 | 14 | 2 | 37059803 | ||
| Pubmed | 3.79e-05 | 23 | 14 | 2 | 26002199 | ||
| Pubmed | 4.13e-05 | 24 | 14 | 2 | 22534482 | ||
| Pubmed | C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. | 5.25e-05 | 27 | 14 | 2 | 29420262 | |
| Pubmed | Full function of exon junction complex factor, Rbm8a, is critical for interneuron development. | 5.65e-05 | 28 | 14 | 2 | 33154347 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 9.94e-05 | 37 | 14 | 2 | 25798587 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.05e-04 | 38 | 14 | 2 | 30786075 | |
| Pubmed | High-Confidence Interactome for RNF41 Built on Multiple Orthogonal Assays. | 1.82e-04 | 50 | 14 | 2 | 29560723 | |
| Pubmed | Proteomic and functional analysis of Argonaute-containing mRNA-protein complexes in human cells. | 2.37e-04 | 57 | 14 | 2 | 17932509 | |
| Pubmed | 3.78e-04 | 72 | 14 | 2 | 36123327 | ||
| Interaction | CACNB2 interactions | 4.69e-07 | 23 | 14 | 3 | int:CACNB2 | |
| Interaction | CACNB1 interactions | 6.08e-07 | 25 | 14 | 3 | int:CACNB1 | |
| Interaction | CACNB4 interactions | 6.08e-07 | 25 | 14 | 3 | int:CACNB4 | |
| Interaction | PPP1R12C interactions | 8.05e-06 | 58 | 14 | 3 | int:PPP1R12C | |
| Interaction | MIA3 interactions | 1.54e-05 | 231 | 14 | 4 | int:MIA3 | |
| Interaction | NALCN interactions | 4.06e-05 | 14 | 14 | 2 | int:NALCN | |
| Interaction | SCN11A interactions | 4.68e-05 | 15 | 14 | 2 | int:SCN11A | |
| Interaction | SCN9A interactions | 9.34e-05 | 21 | 14 | 2 | int:SCN9A | |
| Interaction | CACNA1D interactions | 1.23e-04 | 24 | 14 | 2 | int:CACNA1D | |
| Interaction | DGKD interactions | 1.33e-04 | 25 | 14 | 2 | int:DGKD | |
| Interaction | SCN1A interactions | 1.80e-04 | 29 | 14 | 2 | int:SCN1A | |
| Interaction | CACNB3 interactions | 2.20e-04 | 32 | 14 | 2 | int:CACNB3 | |
| Interaction | CACNA1B interactions | 2.94e-04 | 37 | 14 | 2 | int:CACNA1B | |
| Interaction | CECR2 interactions | 4.56e-04 | 46 | 14 | 2 | int:CECR2 | |
| Interaction | EDC4 interactions | 4.62e-04 | 226 | 14 | 3 | int:EDC4 | |
| Interaction | SCN5A interactions | 4.76e-04 | 47 | 14 | 2 | int:SCN5A | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.89e-05 | 26 | 10 | 2 | 253 | |
| GeneFamily | EF-hand domain containing | 1.98e-04 | 219 | 10 | 3 | 863 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 2.04e-05 | 175 | 14 | 3 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 2.04e-05 | 175 | 14 | 3 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-ILC|Multiple_Sclerosis / Disease, condition lineage and cell class | 3.04e-05 | 200 | 14 | 3 | ab9bdc9365cbdffe4ed246ce0c8a008a390e387e | |
| Drug | IAA-94 | 4.57e-08 | 61 | 14 | 4 | CID000003667 | |
| Drug | IHC-64 | 9.99e-07 | 33 | 14 | 3 | CID000162753 | |
| Drug | CNS 1145 | 9.99e-07 | 33 | 14 | 3 | CID000190902 | |
| Drug | AC 110 | 2.11e-06 | 4 | 14 | 2 | CID000022860 | |
| Drug | S 8510 | 3.51e-06 | 5 | 14 | 2 | CID005488383 | |
| Drug | Cinildipine | 5.03e-06 | 56 | 14 | 3 | CID000002752 | |
| Drug | alpha-sialylcholesterol | 5.26e-06 | 6 | 14 | 2 | CID000133976 | |
| Drug | 3,4-dihydroquinazoline | 5.26e-06 | 6 | 14 | 2 | CID000583065 | |
| Drug | gadolinium | 5.29e-06 | 199 | 14 | 4 | CID000023982 | |
| Drug | nilvadipine | 6.20e-06 | 60 | 14 | 3 | CID000004494 | |
| Drug | lercanidipine | 7.19e-06 | 63 | 14 | 3 | CID000065866 | |
| Drug | APMPA | 7.36e-06 | 7 | 14 | 2 | CID000512300 | |
| Drug | mibefradil | 7.54e-06 | 64 | 14 | 3 | CID000060662 | |
| Drug | gallopamil | 8.66e-06 | 67 | 14 | 3 | CID000001234 | |
| Drug | AC1L2AC7 | 9.47e-06 | 69 | 14 | 3 | CID000068733 | |
| Drug | CAS 298-57-7 | 1.12e-05 | 73 | 14 | 3 | CID000002761 | |
| Drug | ethosuximide | 1.17e-05 | 74 | 14 | 3 | CID000003291 | |
| Drug | nisoldipine | 1.37e-05 | 78 | 14 | 3 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.42e-05 | 79 | 14 | 3 | CID005287890 | |
| Drug | 4-aminopiperidine | 1.92e-05 | 11 | 14 | 2 | CID000424361 | |
| Drug | leys | 1.92e-05 | 11 | 14 | 2 | CID000484683 | |
| Drug | AC1NUZ8M | 2.25e-05 | 92 | 14 | 3 | CID000073211 | |
| Drug | AC1L2VU3 | 2.31e-05 | 12 | 14 | 2 | CID000129572 | |
| Drug | manidipine | 2.48e-05 | 95 | 14 | 3 | CID000004008 | |
| Drug | isotetrandrine | 2.64e-05 | 97 | 14 | 3 | CID000005422 | |
| Drug | nitrendipine | 2.72e-05 | 98 | 14 | 3 | CID000004507 | |
| Drug | isradipine | 2.89e-05 | 100 | 14 | 3 | CID000003784 | |
| Drug | AC1L1JG6 | 3.18e-05 | 14 | 14 | 2 | CID000005026 | |
| Drug | loperamide | 3.34e-05 | 105 | 14 | 3 | CID000003954 | |
| Drug | butamben | 3.67e-05 | 15 | 14 | 2 | CID000002482 | |
| Drug | pentasulfane | 4.19e-05 | 16 | 14 | 2 | CID000448216 | |
| Drug | Verapamil | 4.19e-05 | 16 | 14 | 2 | DB00661 | |
| Drug | lamotrigine | 4.50e-05 | 116 | 14 | 3 | CID000003878 | |
| Drug | AC1NBU2S | 4.62e-05 | 117 | 14 | 3 | CID004473765 | |
| Drug | Potassium Chloride | 4.62e-05 | 117 | 14 | 3 | ctd:D011189 | |
| Drug | 4-aminohexanoic Acid | 5.34e-05 | 18 | 14 | 2 | CID000138490 | |
| Drug | bepridil | 5.76e-05 | 126 | 14 | 3 | CID000002351 | |
| Drug | pimozide | 5.90e-05 | 127 | 14 | 3 | CID000016362 | |
| Drug | pranidipine | 5.97e-05 | 19 | 14 | 2 | CID006436048 | |
| Drug | N6-Me-dAdo | 5.97e-05 | 19 | 14 | 2 | CID000168948 | |
| Drug | Linuron | 6.04e-05 | 128 | 14 | 3 | ctd:D008044 | |
| Drug | lanthanum | 7.23e-05 | 136 | 14 | 3 | CID000023926 | |
| Drug | cobalt-60 | 7.41e-05 | 390 | 14 | 4 | CID000061492 | |
| Drug | isovalerate | 8.39e-05 | 143 | 14 | 3 | CID000010430 | |
| Drug | Dantrolene-13C3 | 8.75e-05 | 145 | 14 | 3 | CID000002951 | |
| Drug | nimodipine | 8.75e-05 | 145 | 14 | 3 | CID000004497 | |
| Drug | nicardipine | 8.75e-05 | 145 | 14 | 3 | CID000004473 | |
| Drug | LY320135 | 8.82e-05 | 23 | 14 | 2 | CID005311257 | |
| Drug | alpha-conotoxin SI | 8.82e-05 | 23 | 14 | 2 | CID000163979 | |
| Drug | barium | 9.30e-05 | 148 | 14 | 3 | CID000104810 | |
| Drug | Bay K 8644 | 9.67e-05 | 150 | 14 | 3 | CID000002303 | |
| Drug | lead compounds | 9.67e-05 | 150 | 14 | 3 | CID000073212 | |
| Drug | procaine | 1.03e-04 | 153 | 14 | 3 | CID000004914 | |
| Drug | procymidone | 1.07e-04 | 155 | 14 | 3 | ctd:C035988 | |
| Drug | melatonin | 1.21e-04 | 443 | 14 | 4 | CID000000896 | |
| Drug | mAHP | 1.22e-04 | 27 | 14 | 2 | CID000220531 | |
| Drug | eniluracil | 1.22e-04 | 27 | 14 | 2 | CID000043157 | |
| Drug | felodipine | 1.38e-04 | 169 | 14 | 3 | CID000003333 | |
| Drug | gabapentin | 1.38e-04 | 169 | 14 | 3 | CID000003446 | |
| Drug | lavendustin A | 1.43e-04 | 171 | 14 | 3 | CID000003894 | |
| Drug | riluzole | 1.50e-04 | 174 | 14 | 3 | CID000005070 | |
| Drug | AC1NDLJ6 | 1.51e-04 | 30 | 14 | 2 | CID004627775 | |
| Drug | papaverine | 1.55e-04 | 176 | 14 | 3 | CID000004680 | |
| Drug | NSC7524 | 1.71e-04 | 182 | 14 | 3 | CID000005657 | |
| Drug | 3-aminopropylphosphinic acid | 1.72e-04 | 32 | 14 | 2 | CID006335948 | |
| Drug | A61603 | 1.83e-04 | 33 | 14 | 2 | CID004038180 | |
| Drug | fluspirilene | 1.95e-04 | 34 | 14 | 2 | CID000003396 | |
| Drug | Aliquat 336 | 1.95e-04 | 34 | 14 | 2 | CID000021218 | |
| Drug | NSC759576 | 1.98e-04 | 191 | 14 | 3 | CID000003075 | |
| Drug | baclofen | 1.98e-04 | 191 | 14 | 3 | CID000002284 | |
| Drug | dihydropyridine | 2.04e-04 | 193 | 14 | 3 | CID000104822 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.04e-04 | 193 | 14 | 3 | 3262_UP | |
| Drug | 3-7a | 2.19e-04 | 36 | 14 | 2 | CID011987860 | |
| Drug | CP-80 | 2.19e-04 | 36 | 14 | 2 | CID000452640 | |
| Drug | Ginkgolide A [15291-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 2.20e-04 | 198 | 14 | 3 | 3260_DN | |
| Drug | ELAN | 2.31e-04 | 37 | 14 | 2 | CID000009469 | |
| Drug | 1-EBIO | 2.31e-04 | 37 | 14 | 2 | CID000082320 | |
| Drug | 8-cyclopentyltheophylline | 2.44e-04 | 38 | 14 | 2 | CID000001917 | |
| Drug | 3,4-diaminopyridine | 2.44e-04 | 38 | 14 | 2 | CID000005918 | |
| Drug | E 14 | 2.57e-04 | 39 | 14 | 2 | CID000122591 | |
| Drug | BMY 7378 | 2.84e-04 | 41 | 14 | 2 | CID000002419 | |
| Drug | AC1L1I54 | 2.84e-04 | 41 | 14 | 2 | CID000004426 | |
| Drug | phenytoin | 2.95e-04 | 219 | 14 | 3 | CID000001775 | |
| Drug | Fk 888 | 2.98e-04 | 42 | 14 | 2 | CID000107967 | |
| Drug | K-Cl | 3.12e-04 | 567 | 14 | 4 | CID000004873 | |
| Drug | AC1L1KGC | 3.20e-04 | 225 | 14 | 3 | CID000005486 | |
| Drug | 5'-CG-3 | 3.27e-04 | 44 | 14 | 2 | CID000482125 | |
| Drug | h PM | 3.42e-04 | 45 | 14 | 2 | CID005494424 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 3.54e-04 | 233 | 14 | 3 | CID000005114 | |
| Drug | KW-3049 | 4.23e-04 | 50 | 14 | 2 | CID000002324 | |
| Drug | nefiracetam | 5.31e-04 | 56 | 14 | 2 | CID000071157 | |
| Drug | prochloraz | 5.33e-04 | 268 | 14 | 3 | ctd:C045362 | |
| Drug | nalidixic acid | 5.87e-04 | 277 | 14 | 3 | CID000004421 | |
| Drug | etorphine | 5.89e-04 | 59 | 14 | 2 | CID000026721 | |
| Drug | gabapentin | 5.89e-04 | 59 | 14 | 2 | ctd:C040029 | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 3.79e-07 | 3 | 11 | 2 | DOID:7474 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 3.79e-07 | 3 | 11 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | fragile X syndrome (implicated_via_orthology) | 3.79e-07 | 3 | 11 | 2 | DOID:14261 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 7.58e-07 | 4 | 11 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 2.65e-06 | 7 | 11 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | age at first birth measurement | 8.81e-04 | 120 | 11 | 2 | EFO_0009101 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.41e-03 | 152 | 11 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.61e-03 | 163 | 11 | 2 | DOID:1826 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RARHREGSRPARGGE | 976 | O00555 | |
| RQERGLGHRVAGRRG | 231 | Q9Y6R9 | |
| KGERRARHRGGPRAG | 951 | Q00975 | |
| RRRGPGRGEDRRRED | 146 | Q96D70 | |
| RGEESRRRPTGGRGR | 476 | P51116 | |
| GKIGGRGRPRQVRRH | 16 | Q8TDF6 | |
| RGSRPYRNRGHGRRG | 471 | Q06787 | |
| VRGEEIIPRGHRRGR | 211 | Q9NP92 | |
| RDRQREGHGRGRGRP | 86 | P05423 | |
| RRGRGQHRRGGVARA | 386 | Q9UL41 | |
| RHGSPGRRKGRAERR | 56 | Q8TAP8 | |
| EGRGRGRDPHRDRTR | 11 | Q9NXX6 | |
| QGRRRRPERGARGGQ | 1316 | P35916 | |
| GAGHPSGRRRRREDQ | 146 | Q13563 | |
| RSRARRGHLGNGDRP | 61 | Q8N1X5 |